(Q37900126)

25 August 2017

1 reference

title

Severity in irritable bowel syndrome: a Rome Foundation Working Team report (English)

1 reference

25 August 2017

main subject

irritable bowel syndrome

1 reference

P Whorwell

8

0 references

author name string

Douglas A Drossman

1

1 reference

25 August 2017

L Chang

2

1 reference

25 August 2017

N Bellamy

3

1 reference

25 August 2017

H E Gallo-Torres

4

1 reference

25 August 2017

A Lembo

5

1 reference

25 August 2017

F Mearin

6

1 reference

25 August 2017

N J Norton

7

1 reference

25 August 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

The American Journal of Gastroenterology

25 August 2017

published in

1 reference

25 August 2017

volume

106

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1749-59; quiz 1760

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2011.201

25 August 2017

exact match

0 references

cites work

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

The irritable bowel syndrome: review and a graduated multicomponent treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Irritable bowel syndrome: toward an understanding of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Health status by gastrointestinal diagnosis and abuse history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Using art to help understand the imagery of irritable bowel syndrome and its response to hypnotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

A treatment trial of acupuncture in IBS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Predictors of patient-assessed illness severity in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.201

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.201

1 reference

Dimensions Publication ID

25 August 2017

1010584439

0 references

1 reference